39
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Factors of Importance for Prediction of Survival in Patients with Metastatic Renal Cell Carcinoma, Treated with or without Nephrectomy

, &
Pages 246-251 | Published online: 09 Jul 2009

REFERENCES

  • Skinner DG, Colvin RB, Vermilion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971; 28: 1165–77.
  • Bukowski RM. Natural history and therapy of metastatic renal cell carcinoma. Cancer 1997; 80: 1198–220.
  • Freed SZ, Halperin JP, Gordon M. Idiopathic regression of metastases from renal carcinoma. J Urol 1977; 118: 538–42.
  • Sobin LH, Wittekind Ch, editors. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997: 180–2.
  • Ljungberg B, Mehle C, Stenling R, Roos G. Hetero-geneity in renal cell carcinoma and its impact on prognosis-a flow cytometric study. Br J Cancer 1996; 74: 123–7.
  • Fowler Jr JE. Nephrectomy in metastatic renal cell carcinoma. Urol Clin North Am 1987; 14: 749–56.
  • Bamley JD, Churchill EJ. Adenocarcinoma of the kidney with metastases to the lung: cured by nephrectomy and lobectomy. J Urol 1939; 42: 269–71.
  • Montie JE, Stewart BH, Straffon RA, Banowsky LH, Hewitt CB, Montague DK. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 1977; 117: 272–5.
  • Thrasher JB, Clark JR, Cleland BP. Surgery for pulmonary metastases from renal cell carcinoma: army experience from 1977-1987. Urology 1990; 35: 487–91.
  • Klugo RC, Detmers M, Stiles RE, Talley RW, Cerny JC. Aggressive versus conservative management of stage IV renal cell carcinoma. J Urol 1977; 118: 244–6.
  • Minasian LM, Motzer RJ, Gluck L. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long term follow-up. J Clin Oncol 1993; 11: 1368–75.
  • Couillard DR, deVere White RW. Surgery of renal cell carcinoma. Urol Clin North Am 1993; 20: 263–75.
  • Marcus SG, Choyke PL, Reiter R, Jaffe GS, Alexander RB, Linehan WM, et al. Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy. J Urol 1993; 150: 463–6.
  • Sella A, Swanson DA, Ro JY, Putnam Jr JB, Amato RJ, Markowitz AB, Logothetis CJ. Surgery following response to interferon-cc-based therapy for residual renal cell carcinoma. J Urol 1993; 149: 19–22.
  • Neves RJ, Zincke H, Taylor WF. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patients survival. J Urol 1988; 139: 1173–6.
  • Maldazys JD, deKemion JB. Prognostic factors in metastatic renal carcinoma. J Urol 1986; 136: 376–9.
  • Uygur MC, Usubutun A, Ozen H, Ayhan A, Kendi S. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma. Int Urol Nephrol 1998; 30: 681–7.
  • Johnson DE, Kaesler KE, Samuels ML. Is nephrectomy justified in patients with metastatic renal carcinoma. J Urol 1975; 114: 27–9.
  • DeKemion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978; 120: 148–52.
  • Mani S, Todd MB, Katz K, Poo WJ. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 1995; 154: 35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.